Clinical trial

An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

NCT01613027

Study summary

ClinicalTrials.gov

An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention Rituximab Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2012-02-01

PhaseN/A

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

RituximabBIOLOGICAL

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Mapped research locations

AthensGreece4 ThessalonikiGreece3 PátraiGreece2 LarissaGreece1 HeraklionGreece1 IoanninaGreece1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01613027 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.